Search
Coagulation
smpdb.ca/view/SMP0130473PhysiologicalExposed collagen from broken vessels binds to factor XII activating it to XIIa which converts prekallikrein and factor XI to kallikrein and factor XIa respectively. … This activator complex of VIIa and TF converts factor X to the activated form.
Enzymes: Tissue factor, Coagulation factor VIIIWarfarin Action Pathway
smpdb.ca/view/SMP0000268Drug actionThrough the two factors coagulation factor Xa and coagulation factor Va, thrombin is produced, which then uses fibrinogen alpha, beta, and gamma chains to create fibrin (loose). … The enzyme vitamin K-dependent gamma carboxylase catalyzes precursors of prothrombin and coagulation factors VII, IX and X to prothrombin, and coagulation factors VII, IX and X.
Enzymes: Tissue factor, Coagulation factor VIIIArgatroban.
smpdb.ca/view/SMP0000276Drug actionArgatroban does not effect serine proteases like, trypsin, factor Xa, plasmin, and kallikrein. … Direct thrombin inhibitors bind plasma and fibrin bound thrombin independently of co-factor antithrombin.The inhibition of thrombin reduces the stability of the clot and promotes clot break down.
Enzymes: Tissue factor, Coagulation factor VIIIAminocaproic Acid Action Pathway
smpdb.ca/view/SMP0000286Drug actionThis blockade inhibits plasminogen binding to fibrin and the conversion of plasminogen to plasmin. These prevents fibrin degradation and maintains the stability of fibrin clots. … Aminocaproic acid, brand name Amicar, is a derivate of lysine and is an antifibrinolytic drug. Antifibrinolytics drugs are commonly used during major surgery to prevent significant blood loss.
Enzymes: Tissue factor, Coagulation factor VIIIDicoumarol Action Pathway
smpdb.ca/view/SMP0000656Drug actionVitamin K-dependent coagulation factors (II, VII, IX, and X) requires its cofactor, vitamin K to facilitate the activation and gamma-carboxylation. … Inhibition of vitamin K reductase results in reduced concentration of vitamin KH2, which will ultimately lead to decreased coagulability of the blood and reduced cleavage of fibrinogen into fibrin.
Enzymes: Tissue factor, Coagulation factor VIIIBivalirudin.
smpdb.ca/view/SMP0000277Drug actionThe inhibition of fibrin prevents the cleavage of fibrinogen into fibrin which activates Factor XIII and Factor XIIIa. … It binds circulating and clot-bound thrombin at the catalytic site and the anion binding exosite.
Enzymes: Tissue factor, Coagulation factor IXLepirudin Action Pathway
smpdb.ca/view/SMP0000278Drug actionLepirudin can also reduce thrombocytopenia and break up clot. … Lepirudin (also known as Refludan) is an anticoagulant that can be used for inhibiting thrombin (prothrombin) irreversibly. Binding of thrombin can prevent formation of clot as well as thrombus.
Enzymes: Tissue factor, Coagulation factor IXAlteplase Action Pathway
smpdb.ca/view/SMP0000280Drug actionAlteplase is the generic version of the drugs Activase and Actilyse. It is a thrombolytic drug prescribed to treat acute myocardial infarctions and other blood clotting conditions. … A side effect of the drug is bleeding, angioedema, allergic reactions and fever.
Enzymes: Tissue factor, Coagulation factor IXAnistreplase Action Pathway
smpdb.ca/view/SMP0000281Drug actionPlasmin breaks down the fibrin of the thrombus to break up the clot and release arterial blockages. … The drug is an acylated streptokinase-plasminogen complex. The acylation of the drug renders it temporarily inactive, protecting it from plasmin inhibitors.
Enzymes: Tissue factor, Coagulation factor IXAprotinin Action Pathway
smpdb.ca/view/SMP0000288Drug actionThe inhibition of kallikrein inhibits factor XIIa production to reduce fibrinolysis and coagulation. Inhibition of plasmin slows down fibrinolysis. … Aprotinin, trade name Trasylol is a bovine serine protease inhibitor of trypsin, chymotrypsin, kallikrein and plasmin.
Enzymes: Tissue factor, Coagulation factor IX